-
Mashup Score: 0Managing Ischemic Heart Disease in Women: Role of a Women’s Heart Center - Current Atherosclerosis Reports - 3 year(s) ago
Purpose of Review Heart centers for women (HCW) were developed due to the rising cardiovascular morbidity and mortality in women in the United States in the early 1990s. Our review encompasses the epidemiology, risk factors, diagnostic strategies, treatments, and the role of HCW in managing women with ischemic heart disease (IHD). Recent Findings HCW use a multidisciplinary team to manage women…
Source: Current Atherosclerosis ReportsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Ambient Air Pollution and Atherosclerosis: Recent Updates - Current Atherosclerosis Reports - 3 year(s) ago
Purpose of Review During the past century, exposure to particulate matter (PM) air pollution < 2.5 μm in diameter (PM2.5) has emerged as an all-pervading element of modern-day society. This increased exposure has come at the cost of heightened risk for cardiovascular (CV) morbidity and mortality. Not only can short-term PM2.5 exposure trigger acute CV events in susceptible individuals, but...
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Managing Ischemic Heart Disease in Women: Role of a Women’s Heart Center - Current Atherosclerosis Reports - 3 year(s) ago
Purpose of Review Heart centers for women (HCW) were developed due to the rising cardiovascular morbidity and mortality in women in the United States in the early 1990s. Our review encompasses the epidemiology, risk factors, diagnostic strategies, treatments, and the role of HCW in managing women with ischemic heart disease (IHD). Recent Findings HCW use a multidisciplinary team to manage women…
Source: Current Atherosclerosis ReportsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5Management of Hypercholesterolemia in Pregnant Women with Atherosclerotic Cardiovascular Disease - Current Atherosclerosis Reports - 3 year(s) ago
Purpose of Review In this review, we discuss strategies for managing dyslipidemia in pregnant women with ASCVD. Recent Findings Cardiovascular disease (CVD) is the leading cause of mortality in women as well as the leading cause of pregnancy-related mortality in the USA. It is paramount to screen, identify, counsel, and treat women of childbearing age who have existing atherosclerotic disease to…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2Management of Hypercholesterolemia in Pregnant Women with Atherosclerotic Cardiovascular Disease - Current Atherosclerosis Reports - 3 year(s) ago
Purpose of Review In this review, we discuss strategies for managing dyslipidemia in pregnant women with ASCVD. Recent Findings Cardiovascular disease (CVD) is the leading cause of mortality in women as well as the leading cause of pregnancy-related mortality in the USA. It is paramount to screen, identify, counsel, and treat women of childbearing age who have existing atherosclerotic disease to…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 4COVID and Cardiovascular Disease: What We Know in 2021 - Current Atherosclerosis Reports - 3 year(s) ago
Purpose of Review Coronavirus disease 2019 (COVID-19) has been the cause of significant global morbidity and mortality. Here, we review the literature to date of the short-term and long-term consequences of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection on the heart. Recent Findings Early case reports described a spectrum of cardiovascular manifestations of COVID-19,…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet-
Our understanding of the impact of COVID-19 on the CV system is constantly evolving #COVID and #CVD :What We Know in 2021 #medtwitter #cardiotwitter https://t.co/FcUzCIuIQO @JamalRanaMD @EricTopol @FaheemYounus @SSharmacardio @DBelardoMD @DrJennHaythe @DrRyanPDaly @fhussain73 https://t.co/fTULMXZewe
-
-
Mashup Score: 8COVID and Cardiovascular Disease: What We Know in 2021 - Current Atherosclerosis Reports - 3 year(s) ago
Purpose of Review Coronavirus disease 2019 (COVID-19) has been the cause of significant global morbidity and mortality. Here, we review the literature to date of the short-term and long-term consequences of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection on the heart. Recent Findings Early case reports described a spectrum of cardiovascular manifestations of COVID-19,…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1The Genetic Basis of Hypertriglyceridemia - 3 year(s) ago
Purpose of Review Hypertriglyceridemia is a common dyslipidemia associated with an increased risk of cardiovascular disease and pancreatitis. Severe hypertriglyceridemia may sometimes be a monogenic condition. However, in the vast majority of patients, hypertriglyceridemia is due to the cumulative effect of multiple genetic risk variants along with lifestyle factors, medications, and disease…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2The Genetic Basis of Hypertriglyceridemia - 3 year(s) ago
Purpose of Review Hypertriglyceridemia is a common dyslipidemia associated with an increased risk of cardiovascular disease and pancreatitis. Severe hypertriglyceridemia may sometimes be a monogenic condition. However, in the vast majority of patients, hypertriglyceridemia is due to the cumulative effect of multiple genetic risk variants along with lifestyle factors, medications, and disease…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1The Role of RNA-Targeted Therapeutics to Reduce ASCVD Risk: What Have We Learned Recently? - 3 year(s) ago
Purpose of Review To discuss advances on the RNA-targeted therapies to treat dyslipidemia with the aim of reducing atherosclerotic cardiovascular disease (ASCVD). Recent Findings Genetic studies have paved the way for therapies that reduce translation of proteins that play causal roles in dyslipidemia and atherosclerosis like proprotein convertase subtilisin/kexin type 9 (PCSK9), apolipoprotein…
Source: Current Atherosclerosis ReportsCategories: Cardiologists, Latest HeadlinesTweet
Managing ischemic heart disease in women: Role of a women's heart center | #THIPubs #THMG @bcostelloMD @SpringerNature #CurrAtherosclerRep https://t.co/ZHM1i5z823 https://t.co/l5D5Pvq1y7